AWM Investment Company’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

AWM Investment Company’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,062,498	Closed	-$22.2M	–	109
2016 Q3	$22.2M	Sell	1,062,498 -115,366	-10%	-$1.33M	4.07%	3
2016 Q2	$12.7M	Sell	1,177,864 -25,957	-2%	-$222K	2.72%	12
2016 Q1	$7.98M	Buy	1,203,821 +408,197	+51%	+$3.71M	1.68%	20
2015 Q4	$14.4M	Hold	795,624	–	–	2.83%	8
2015 Q3	$8.76M	Sell	795,624 -76,376	-9%	-$812K	1.7%	18
2015 Q2	$12.6M	Hold	872,000	–	–	1.78%	15
2015 Q1	$10.2M	Buy	872,000 +47,000	+6%	+$634K	1.41%	20
2014 Q4	$13.7M	Buy	+825,000	New	+$12.1M	1.87%	11

AWM Investment Company's VTAE Position: Q4 2016 in Review

AWM Investment Company sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 1,062,498 shares — an estimated $22.2M sold.

AWM Investment Company first reported a position in VTAE in Q4 2014 and held it in 8 quarters. The position peaked at $22.2M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

AWM Investment Company reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
AWM Investment Company sold 1,062,498 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $22.2M.
AWM Investment Company first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 8 quarters.
AWM Investment Company's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $22.2M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on AWM Investment Company's 13F filing for Q4 2016, filed 2 Feb 2017.